ID

29009

Descrizione

Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT01029704

collegamento

https://clinicaltrials.gov/show/NCT01029704

Keywords

versioni (1)
  1. 20/02/18 20/02/18 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

20 febbraio 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Diabetes Mellitus Type 2 NCT01029704

Inglese

Eligibility Diabetes Mellitus Type 2 NCT01029704

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female between the ages of 18 and 70 years diagnosed with type 2 diabetes.
Descrizione

Age | Diabetes Mellitus, Non-Insulin-Dependent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0011860
body mass index (bmi) between 18 kg/m2 and 37 kg/m2 (inclusive).
Descrizione

Body mass index

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1305855
hba1c levels between 6.5 and 9.5 (inclusive) where the upper limit of normal for the hba1c assay is 6.4% or hba1c levels between 6.2 and 9.5% (inclusive) where the upper limit of normal for the hba1c assay is 6.1%.
Descrizione

Glucohemoglobin measurement | Relationship Upper Limit of Normal

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0202054
UMLS CUI [2,1]
C0439849
UMLS CUI [2,2]
C1519815
fasting plasma glucose levels between 126 and 270 mg/dl (7 - 15 mmol/l, inclusive) while on diabetic medications.
Descrizione

Plasma fasting glucose measurement | Intake Antidiabetics

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0583513
UMLS CUI [2,1]
C1512806
UMLS CUI [2,2]
C0935929
treatment naïve subjects with hba1c between 6.5 and 9.5 and fasting plasma glucose between 126 and 270 mg/dl (7 - 15 mmol/l).
Descrizione

Study Subject Therapy naive | Glucohemoglobin measurement | Plasma fasting glucose measurement

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0919936
UMLS CUI [2]
C0202054
UMLS CUI [3]
C0583513
if taking drugs for diabetes, must be medically able and willing to discontinue diabetic medications for the duration of the study.
Descrizione

Antidiabetics Discontinue Able | Antidiabetics Discontinue Willing

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C0085732
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1444662
UMLS CUI [2,3]
C0600109
female subjects must be surgically sterilized or postmenopausal.
Descrizione

Gender | Female Sterilization | Postmenopausal state

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0015787
UMLS CUI [3]
C0232970
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 diabetes or diabetes treated with insulin injection.
Descrizione

Diabetes Mellitus, Insulin-Dependent | Injection of insulin Diabetes Mellitus

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2,1]
C0199782
UMLS CUI [2,2]
C0011849
insulin therapy or oral antidiabetic medication other than metformin, sitagliptin, saxagliptin, a sulfonylurea or combination of these.
Descrizione

Insulin regime | Antidiabetics Oral | Exception Metformin | Exception sitagliptin | Exception saxagliptin | Exception Sulfonylurea | Exception Combination Pharmaceutical Preparations Specified

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0557978
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0025598
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1565750
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C1611934
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0038766
UMLS CUI [7,1]
C1705847
UMLS CUI [7,2]
C0205195
UMLS CUI [7,3]
C0013227
UMLS CUI [7,4]
C0205369
sitting blood pressure above 150/95 mmhg on two evaluations at least 10 minutes apart at screening.
Descrizione

Sitting blood pressure | Evaluation Quantity

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0580946
UMLS CUI [2,1]
C1261322
UMLS CUI [2,2]
C1265611
positive results on screen for drugs of abuse.
Descrizione

Drug screen positive | Drug abuse

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0743295
UMLS CUI [2]
C0013146
previous treatment with an investigational drug within 30 days or 7 half-lives, whichever is longer.
Descrizione

Investigational New Drugs

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013230
previous treatment with egt0001474 or egt0001442.
Descrizione

Other Coding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3846158
Ritorna all'inizio della pagina

Similar models

Eligibility Diabetes Mellitus Type 2 NCT01029704

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Age | Diabetes Mellitus, Non-Insulin-Dependent
Item
male or female between the ages of 18 and 70 years diagnosed with type 2 diabetes.
boolean
C0001779 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
Body mass index
Item
body mass index (bmi) between 18 kg/m2 and 37 kg/m2 (inclusive).
boolean
C1305855 (UMLS CUI [1])
Glucohemoglobin measurement | Relationship Upper Limit of Normal
Item
hba1c levels between 6.5 and 9.5 (inclusive) where the upper limit of normal for the hba1c assay is 6.4% or hba1c levels between 6.2 and 9.5% (inclusive) where the upper limit of normal for the hba1c assay is 6.1%.
boolean
C0202054 (UMLS CUI [1])
C0439849 (UMLS CUI [2,1])
C1519815 (UMLS CUI [2,2])
Plasma fasting glucose measurement | Intake Antidiabetics
Item
fasting plasma glucose levels between 126 and 270 mg/dl (7 - 15 mmol/l, inclusive) while on diabetic medications.
boolean
C0583513 (UMLS CUI [1])
C1512806 (UMLS CUI [2,1])
C0935929 (UMLS CUI [2,2])
Study Subject Therapy naive | Glucohemoglobin measurement | Plasma fasting glucose measurement
Item
treatment naïve subjects with hba1c between 6.5 and 9.5 and fasting plasma glucose between 126 and 270 mg/dl (7 - 15 mmol/l).
boolean
C0681850 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C0202054 (UMLS CUI [2])
C0583513 (UMLS CUI [3])
Antidiabetics Discontinue Able | Antidiabetics Discontinue Willing
Item
if taking drugs for diabetes, must be medically able and willing to discontinue diabetic medications for the duration of the study.
boolean
C0935929 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
C0935929 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C0600109 (UMLS CUI [2,3])
Gender | Female Sterilization | Postmenopausal state
Item
female subjects must be surgically sterilized or postmenopausal.
boolean
C0079399 (UMLS CUI [1])
C0015787 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent | Injection of insulin Diabetes Mellitus
Item
type 1 diabetes or diabetes treated with insulin injection.
boolean
C0011854 (UMLS CUI [1])
C0199782 (UMLS CUI [2,1])
C0011849 (UMLS CUI [2,2])
Insulin regime | Antidiabetics Oral | Exception Metformin | Exception sitagliptin | Exception saxagliptin | Exception Sulfonylurea | Exception Combination Pharmaceutical Preparations Specified
Item
insulin therapy or oral antidiabetic medication other than metformin, sitagliptin, saxagliptin, a sulfonylurea or combination of these.
boolean
C0557978 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0025598 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C1565750 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C1611934 (UMLS CUI [5,2])
C1705847 (UMLS CUI [6,1])
C0038766 (UMLS CUI [6,2])
C1705847 (UMLS CUI [7,1])
C0205195 (UMLS CUI [7,2])
C0013227 (UMLS CUI [7,3])
C0205369 (UMLS CUI [7,4])
Sitting blood pressure | Evaluation Quantity
Item
sitting blood pressure above 150/95 mmhg on two evaluations at least 10 minutes apart at screening.
boolean
C0580946 (UMLS CUI [1])
C1261322 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Drug screen positive | Drug abuse
Item
positive results on screen for drugs of abuse.
boolean
C0743295 (UMLS CUI [1])
C0013146 (UMLS CUI [2])
Investigational New Drugs
Item
previous treatment with an investigational drug within 30 days or 7 half-lives, whichever is longer.
boolean
C0013230 (UMLS CUI [1])
Other Coding
Item
previous treatment with egt0001474 or egt0001442.
boolean
C3846158 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial